Literature DB >> 11092564

Mitigation of surfactant erythrocyte toxicity by egg phosphatidylcholine.

L A Gould1, A B Lansley, M B Brown, B Forbes, G P Martin.   

Abstract

Polyoxyethylene alkyl ether surfactants have been shown to have excellent penetration enhancing abilities although they are associated with a high level of local toxicity. We have compared the toxicity of a range of polyoxyethylene alkyl ethers (Brij 96, Brij 76, Brij 56, 10 lauryl ether and 9 lauryl ether) to an anionic surfactant (sodium dodecyl sulphate (SDS)), an ampholytic surfactant (lysophosphatidylcholine) and a cationic surfactant (tetradecyltrimethylammonium bromide (TTAB)), in the presence and absence of egg phosphatidylcholine. The toxicity of the surfactants or phospholipid/surfactant mixtures was assessed by measuring haemolytic activity. The test samples were incubated with a suspension of red blood cells for 30 min and Drabkin's reagent was used to indicate the amount of haemoglobin released. All of the polyoxyethylene alkyl ethers, SDS, TTAB and lysophosphatidylcholine exhibited haemolytic activity at concentrations between 0.10 and 0.25 mM. The addition of egg phosphatidylcholine reduced the toxicity for all of the surfactants, with the toxicity of Brij 96 being mitigated to a greater extent than the toxicity of the other polyoxyethylene surfactants examined. The rate of haemolysis induced by Brij 96 or 10 lauryl ether was also reduced by increasing concentrations of phosphatidylcholine. As the phosphatidylcholine content of a mixed surfactant system comprising egg phosphatidylcholine: Brij 96 was replaced by lysophosphatidylcholine and fatty acid, the haemolytic action of the mixture increased markedly. The results from this study show that the toxicity of surfactants to erythrocytes can be mitigated by the addition of egg phosphatidylcholine. Synthetic surfactants combined with phosphatidylcholine may generate drug delivery systems worthy of more extensive investigation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092564     DOI: 10.1211/0022357001777333

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  SF5- and SCF3-substituted tetrahydroquinoline compounds as potent bactericidal agents against multidrug-resistant persister Gram-positive bacteria.

Authors:  Kenneth I Onyedibe; Neetu Dayal; Herman O Sintim
Journal:  RSC Med Chem       Date:  2021-08-10

2.  Biophysical Effects of a Polymeric Biosurfactant in Candida krusei and Candida albicans Cells.

Authors:  Gabriella Freitas Ferreira; Bruna Lorrana Dos Santos Pinto; Eliene Batista Souza; José Lima Viana; Adrielle Zagmignan; Julliana Ribeiro Alves Dos Santos; Áquila Rodrigues Costa Santos; Priscila Batista Tavares; Ângelo Márcio Leite Denadai; Andrea Souza Monteiro
Journal:  Mycopathologia       Date:  2016-08-27       Impact factor: 2.574

Review 3.  Authorization and Toxicity of Veterinary Drugs and Plant Protection Products: Residues of the Active Ingredients in Food and Feed and Toxicity Problems Related to Adjuvants.

Authors:  Szandra Klátyik; Péter Bohus; Béla Darvas; András Székács
Journal:  Front Vet Sci       Date:  2017-09-04

4.  Synthesis and Appraisal of Natural Drug-Polymer-Based Matrices Relevant to the Application of Drug-Eluting Coronary Stent Coatings.

Authors:  Bakhtawar Ghafoor; Murtaza Najabat Ali; Zainab Riaz
Journal:  Cardiol Res Pract       Date:  2020-11-17       Impact factor: 1.866

5.  Physical properties and biological activity of poly(butyl acrylate-styrene) nanoparticle emulsions prepared with conventional and polymerizable surfactants.

Authors:  Julio C Garay-Jimenez; Danielle Gergeres; Ashley Young; Daniel V Lim; Edward Turos
Journal:  Nanomedicine       Date:  2009-02-13       Impact factor: 5.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.